Home › Products › Oncology › Oncotar 100mg Injection

Oncotar 100mg Injection

Salt Composition: CYTARABINE

₹104.00₹130.50

Inclusive of all taxes

Oncotar 100mg Injection

Categories: Oncology

Conditions: Anti Cancer

Product Introduction

Oncotar 100mg injection contains cytarabine as its active substance. It is an antineoplastic drug belonging to the antimetabolite class. It is used alone or in combination with other chemotherapy medications to treat certain types of leukaemias (a blood cancer characterised by excess white blood cells), including acute myeloid leukaemia (AML) and chronic myelogenous leukaemia (CML). It is also indicated for use alone or with other chemotherapy drugs to treat and prevent meningeal leukaemia (cancer of the membrane covering and protecting the spinal cord and brain). Do not use Oncotar 100mg injection if you are allergic to cytarabine or any other ingredients in this medicine. Inform your doctor if you have coordination difficulties, are taking any other anti-cancer medications, have decreased bone marrow function, have liver problems, or have undergone dialysis immediately before or after treatment with this medicine. This medicine may increase uric acid levels in your blood; your doctor will advise whether you require medication to manage this. Notify your doctor if you experience sudden signs of allergy such as rash, itching, or hives on the skin, swelling of the face, lips, mouth, or throat, shortness of breath, or wheezing. The safety of this medicine in patients with kidney failure is not established; inform your doctor if you have any kidney disease.

Uses

Acute myeloid leukemia (AML) Chronic myelogenous leukemia (CML) Meningeal leukemia

How it works

Oncotar 100mg injection is a cytotoxic drug that acts by primarily killing cells undergoing DNA synthesis. It works by slowing or stopping the growth of cancer cells in your body.

How to Use

Oncotar 100mg injection will be given to you in a hospital setting by a trained healthcare professional. This medicine may be given by solution for injection/infusion (using a syringe) under the skin (subcutaneous) or into a vein (intravenously) or into a muscle (intramuscularly), or into the spine (intrathecal). Your doctor will decide the dose, route of administration, and duration of the treatment based on your disease condition, severity, and other factors.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Fever Loss of appetite, abdominal pain Swallowing difficulties Nausea, vomiting Diarrhoea Inflammation or ulceration in the mouth or anus High blood uric acid levels Hair loss Skin rashes Speaking difficulties Inflammation in the vein Serious Swelling and irritation of the skin Increased blood uric acid levels Blisters of the skin Irregular heart beat Lung diseases Anemia Infection Kidney problems

Expert Tips

During the treatment with oncotar 100mg injection, administration of vaccines is not advised. If required, consult your doctor. This medicine may cause infertility in men and women. Your doctor will do blood tests regularly to check whether the medicine works. Inform your physician if you have any ulcers or bleeding in the stomach, or intestines. This medicine may make you bleed or bruise easily; take precautions to prevent the illness.

References

  1. Cytarabine Injection. [cited 2020 Dec 3]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/071868s032lbl.pdf
  2. Cytarabine Injection Solution 100 mg/ml - Summary of Product Characteristics (SmPC) - (emc) [Internet]. www.medicines.org.uk. [revised on 2020] [cited 2023 Mar 30]. Available from: https://www.medicines.org.uk/emc/product/1570/smpc
  3. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1698 – 1699.
  4. KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 864 - 865.

Safety Advice

Pregnancy: unsafe Oncotar 100mg injection is unsafe to administer in pregnant women because it may cause birth defects. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for 6 months after your last dose is necessary.

Lungs: Consult your doctor It is unknown whether oncotar 100mg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.

Breastfeeding: unsafe Breastfeeding is not recommended in patients taking oncotar 100mg injection because the medicine passes into the breast milk in small amounts and may harm your baby.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS